| Literature DB >> 26200013 |
Hideaki Morita1, Ken Arae2, Hirotoshi Unno3, Kousuke Miyauchi4, Sumika Toyama5, Aya Nambu6, Keisuke Oboki7, Tatsukuni Ohno8, Kenichiro Motomura7, Akira Matsuda9, Sachiko Yamaguchi10, Seiko Narushima10, Naoki Kajiwara7, Motoyasu Iikura11, Hajime Suto12, Andrew N J McKenzie13, Takao Takahashi14, Hajime Karasuyama15, Ko Okumura12, Miyuki Azuma16, Kazuyo Moro17, Cezmi A Akdis18, Stephen J Galli19, Shigeo Koyasu20, Masato Kubo21, Katsuko Sudo22, Hirohisa Saito7, Kenji Matsumoto7, Susumu Nakae23.
Abstract
House dust mite-derived proteases contribute to allergic disorders in part by disrupting epithelial barrier function. Interleukin-33 (IL-33), produced by lung cells after exposure to protease allergens, can induce innate-type airway eosinophilia by activating natural helper (NH) cells, a member of group 2 innate lymphoid cells (ILC2), to secrete Th2 type-cytokines. Because IL-33 also can induce mast cells (MCs) to secrete Th2 type-cytokines, MCs are thought to cooperate with NH cells in enhancing protease or IL-33-mediated innate-type airway eosinophilia. However, we found that MC-deficient Kit(W-sh/W-sh) mice exhibited exacerbated protease-induced lung inflammation associated with reduced numbers of regulatory T (Treg) cells. Moreover, IL-2 produced by IL-33-stimulated MCs promoted expansion of numbers of Treg cells, thereby suppressing development of papain- or IL-33-induced airway eosinophilia. We have thus identified a unique anti-inflammatory pathway that can limit induction of innate-type allergic airway inflammation mediated by NH cells.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26200013 PMCID: PMC4533925 DOI: 10.1016/j.immuni.2015.06.021
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745